Radiopharm Theranostics L... (RADX)
NASDAQ: RADX
· Real-Time Price · USD
6.00
0.40 (7.14%)
At close: Sep 05, 2025, 10:03 AM
7.14% (1D)
| Bid | 5.62 |
| Market Cap | 7.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -3.44 |
| PE Ratio (ttm) | -1.74 |
| Forward PE | -1.57 |
| Analyst | Buy |
| Ask | 7.18 |
| Volume | 4,034 |
| Avg. Volume (20D) | 28,466 |
| Open | 5.70 |
| Previous Close | 5.60 |
| Day's Range | 5.70 - 6.00 |
| 52-Week Range | 3.50 - 50.82 |
| Beta | 0.81 |
About RADX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RADX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RADX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+4.9%
Radiopharm Theranostics shares are trading higher ...
Unlock content with
Pro Subscription
3 months ago
+11.18%
Radiopharm Theranostics shares are trading higher after the company announced preclinical data from studies with the Lu177-B7H3-monoclonal antibody RV01.